143 related articles for article (PubMed ID: 9259692)
1. Incidence and prevalence of ESRD. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S40-53. PubMed ID: 9259692
[TBL] [Abstract][Full Text] [Related]
2. Pediatric end-stage renal disease. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S128-44. PubMed ID: 9259698
[No Abstract] [Full Text] [Related]
3. USRDS: the United States Renal Data System.
Am J Kidney Dis; 2003 Dec; 42(6 Suppl 5):1-230. PubMed ID: 14655174
[No Abstract] [Full Text] [Related]
4. 1998 U.S. Renal Data System report. Incidence rate remains steady, improvements seen in survival.
Nephrol News Issues; 1998 Sep; 12(9):18-9, 23. PubMed ID: 9923292
[No Abstract] [Full Text] [Related]
5. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
6. International comparisons of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S187-94. PubMed ID: 9259702
[No Abstract] [Full Text] [Related]
7. Analytical methods. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S195-213. PubMed ID: 9259703
[No Abstract] [Full Text] [Related]
8. Incidence and prevalence of ESRD. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S38-49. PubMed ID: 9713406
[No Abstract] [Full Text] [Related]
9. Patient mortality and survival. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S86-106. PubMed ID: 9259695
[No Abstract] [Full Text] [Related]
10. Completeness and reliability of USRDS data: comparisons with the Michigan Kidney Registry.
Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):84-8. PubMed ID: 1442779
[TBL] [Abstract][Full Text] [Related]
11. Causes of death. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S107-17. PubMed ID: 9259696
[No Abstract] [Full Text] [Related]
12. Treatment modalities for ESRD patients. USRDS. United State Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S54-66. PubMed ID: 9259693
[No Abstract] [Full Text] [Related]
13. International comparisons of ESRD therapy. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S136-41. PubMed ID: 9713416
[No Abstract] [Full Text] [Related]
14. Excerpts from the 1993 USRDS Annual Data Report.
Am J Kidney Dis; 1993 Oct; 22(4 Suppl 2):1-118. PubMed ID: 7848383
[No Abstract] [Full Text] [Related]
15. Annual facility survey of providers of ESRD therapy. USRDS. United States Renal Data System.
Am J Kidney Dis; 1997 Aug; 30(2 Suppl 1):S178-86. PubMed ID: 9259701
[No Abstract] [Full Text] [Related]
16. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States.
Kitiyakara C; Eggers P; Kopp JB
Am J Kidney Dis; 2004 Nov; 44(5):815-25. PubMed ID: 15492947
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and cost of ESRD therapy.
Am J Kidney Dis; 1991 Nov; 18(5 Suppl 2):21-9. PubMed ID: 1951354
[No Abstract] [Full Text] [Related]
18. Pediatric end-stage renal disease. United States Renal Data System.
Am J Kidney Dis; 1998 Aug; 32(2 Suppl 1):S98-108. PubMed ID: 9713412
[No Abstract] [Full Text] [Related]
19. Improvements in data quality in the USRDS database: determining treatment modalities.
Am J Kidney Dis; 1992 Nov; 20(5 Suppl 2):89-94. PubMed ID: 1442780
[TBL] [Abstract][Full Text] [Related]
20. Projecting the number of patients with end-stage renal disease in the United States to the year 2015.
Gilbertson DT; Liu J; Xue JL; Louis TA; Solid CA; Ebben JP; Collins AJ
J Am Soc Nephrol; 2005 Dec; 16(12):3736-41. PubMed ID: 16267160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
